By Josh White
Date: Wednesday 07 Jan 2026
| GSK chronic hepatitis B treatment hits goal in t... | 07-Jan-2026 | ShareCast |
| Japan approves GSK treatment for severe asthma | 06-Jan-2026 | ShareCast |
| GSK's COPD treatment approved by Chinese regulat... | 05-Jan-2026 | ShareCast |
| Suspension - Beximco Pharmaceuticals PLC | 02-Jan-2026 | ShareCast |
| Total Voting Rights | 02-Jan-2026 | ShareCast |
| Holding(s) in Company | 07-Jan-2026 | 11:00 | RNS |
| EC approval of Shingrix PFS | 07-Jan-2026 | 07:05 | RNS |
| US Patent allowance for PTSD discovery programme | 07-Jan-2026 | 07:00 | RNS |
| Mevalone Label Extension in France | 07-Jan-2026 | 07:00 | RNS |
| Positive phase 3 data for GSK's bepirovirsen | 07-Jan-2026 | 07:00 | RNS |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:BTG | 06-Oct-2011 | The Independent |
| Investment Column:Genus | 09-Sep-2011 | The Independent |
| Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
| Price | 26,202.22 |
| Closing Price Change | 1,089.72 |
| % Change | 4.34 % |
| 06-Jan-26 Close | 26,202.22 |
You are here: research